Single Rising Dose (SRD), Multiple Rising Dose (MRD) Study of BI 671800 in Healthy Asian Volunteers

Conditions:   Asthma;   Rhinitis, Allergic, Perennial
Interventions:   Drug: BI 671800;   Drug: placebo
Sponsor:   Boehringer Ingelheim Pharmaceuticals
Recruiting – verified October 2010

View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days